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During the 2001, 2002, and 2003 enterovirus seasons, we investigated the correlations between cerebrospinal
fluid (CSF) nucleated cell counts and elevated CSF protein levels and the detection of enteroviral RNA by
reverse transcription (RT)-PCR. Our objective was to determine if pleocytosis and/or elevated protein levels
were predictive of positive RT-PCR results for enterovirus. We were also interested in determining if the
presence of West Nile virus during the 2002 enteroviral season contributed to a change in these correlations.
We found that in the group of patients aged >2 months, the absence of pleocytosis was highly predictive of a
negative RT-PCR result. Elevated CSF protein level was not a good predictor of RT-PCR positivity for
enterovirus and did not add to the diagnostic sensitivity or specificity of pleocytosis.
able for 2001 and 2002 only) for patients for whom EV RTPCR of CSF samples had been requested. Our suspicion that
CSF with a nucleated cell count of ⱕ5 per mm3 from patients
more than 2 months old was not likely to be RT-PCR positive
proved to be true, although a large number of CSF samples
with high cell counts did not test positive for EV.

Enteroviruses (EVs) cause annual seasonal epidemics of
aseptic meningitis in temperate climates and are the most
common cause of this clinical syndrome in the United States.
The infections are most clinically noticeable in children, but
they are also clearly present in adults (9). The viruses are
maintained within the human population in tropical climates
year-round and at low but detectable levels in both children
and adults during the cold months in temperate climates (3).
Reverse transcription (RT)-PCR has become the method of
choice for the rapid and efficient diagnosis of EV infections
from cerebrospinal fluid (CSF). The use of commercially available (6, 11, 12, 20) and in-house assay methods (6) is currently
common in molecular diagnostic virology laboratories and often results in fewer tests being performed, less medication
being used, and earlier release from the hospital than with
previous diagnostic methods for patients with CSF samples
with positive RT-PCR results for EV (EV RT-PCR) and negative Gram stains (4, 8, 10, 14, 15).
Whether CSF pleocytosis plays an important role in defining
aseptic meningitis or in prioritizing the differential diagnosis
has been investigated but is still not completely clear (7, 14,
17). In this era of rapidly rising health care costs, it is important, if possible, to limit laboratory-based testing by encouraging syndrome-directed testing and actively discouraging testing
that is not consistent with the clinical picture or with other
laboratory results. Additionally, quality control within the laboratory can be enhanced by monitoring laboratory-based data
to look for important correlations that will provide insight for
clinicians and laboratory workers with regard to future testing
requests.
During the 2001, 2002, and 2003 EV seasons, we collected
all available CSF cell count data and CSF protein data (avail-

MATERIALS AND METHODS
CSF specimens (n ⫽ 1,706) were submitted to the St. Louis Children’s Hospital Virology Laboratory during the 2001, 2002, and 2003 EV seasons (roughly
May to November of each year) for EV RT-PCR testing. Relevant CSF cell
count data was available from the laboratory information system for 728 of the
patients who were seen at Washington University Medical Center and tested by
EV RT-PCR. Of the patients included in the study, 549 were pediatric (ⱕ18
years of age) and 179 were adults. The data analyzed included patient age, EV
RT-PCR result (243 positive and 485 negative), CSF white blood cell count, and
CSF protein level. Pleocytosis was defined as a CSF cell count of ⬎22 cells/mm3
if the patient’s age was ⬍4 weeks, ⬎15 cells/mm3 if the patient’s age was 4 to 8
weeks, and ⬎5 cells/mm3 if the patient’s age was ⬎8 weeks (1). The cutoffs to
identify elevated levels of CSF protein were those determined by a study at our
institution in which EV RT-PCR was performed on all specimens to eliminate
any samples from patients with unsuspected EV infections (19). Those cutoffs
were as follows: ⱖ111 mg/dl for patients aged ⱕ2 months, ⱖ79 mg/dl for patients
aged ⬎2 months to 4 months, ⱖ34 mg/dl for patients aged ⬎4 months to 14
years, ⱖ37 mg/dl for patients aged ⬎14 years to 18 years, and ⱖ46 mg/dl for
patients aged ⬎18 years. When there was CSF pleocytosis (as defined above for
each age group) in a patient with a negative EV RT-PCR result during 2002, the
results of other bacterial and viral tests performed on the patient were reviewed.
RNA was extracted manually from 140 l of CSF by using QIAamp Viral
RNA Mini Spin columns. This procedure allows purification of viral nucleic acids
from cell-free fluid samples, and the columns were used in accordance with the
manufacturer’s instructions.
The Chemicon Light Diagnostics Pan-Enterovirus ASR kit was used for the
qualitative detection of EV RNA through RT-PCR amplification of the 5⬘
untranslated region of the EV genome. Extracted RNA was combined with
reaction mix (QIAGEN RT-PCR mix and Chemicon Pan-Entero Primer mix)
and amplified with a Perkin-Elmer 2400 thermocycler. Detection of the amplified
product was performed by using a Chemicon Light Diagnostics Pan-Enterovirus
hybridization capture assay. Using a serially diluted stock of ECHO 11 grown in
cell culture, we determined the analytic sensitivity of the Chemicon assay to be
1.9 times the 50% tissue culture infective dose. The primers and probe for the
Chemicon assay have been shown to detect all but 6 of the 64 known EVs that
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TABLE 1. Results of EV RT-PCR by age group and year
Age group

No. positive/no. tested (%) for yr indicated
2001

2002

2003

TABLE 2. Presence of pleocytosis and EV RT-PCR results for
2001, 2002, and 2003a

Total

All ages 117/243 (48.1) 44/219 (20.1) 83/266 (31.2) 277/728 (38.1)
ⱕ2 mo
43/68 (63.2) 24/47 (51.1) 16/64 (27.3)
83/179 (46.4)
⬎2 mo
61/127 (48.0) 18/100 (18) 61/143 (42.7) 140/370 (37.8)
and
ⱕ18 yr
⬎18 yr
13/48 (27.1)
2/72 (2.8)
5/59 (8.5)
20/179 (11.2)

RESULTS
Of the 1,706 specimens submitted for EV RT-PCR during
the three study seasons, 570 (33.4%) tested positive and 1,136
(67%) tested negative. As shown in Table 1, a higher percentage of submitted specimens (48%) was positive in 2001 than in
2002 (20%) or 2003 (31%). In two of the three seasons (2001
and 2002), the percentage of specimens that was positive was
highest for infants ⱕ2 months of age. In all three seasons, the
percentage of specimens that was positive was lowest among
those ⬎18 years of age.
We used the 728 samples for which CSF parameters were
available to examine the relationship between CSF pleocytosis
and results of EV RT-PCR. The percentage of the 728 specimens that was EV RT-PCR positive (33.5%) was very similar
to the percentage of the entire group of specimens that was
positive (33.4% [570 of 1,706]). Over all three seasons, pleocytosis was present in 410 of 728 patients (56%) for whom CSF
cell count data was available, including 216 (88.5%) of those
with EV RT-PCR-positive results and 194 (40.1%) of those
with EV RT-PCR-negative results. As shown in Table 2, the
sensitivity, specificity, positive predictive value (PPV), and negative predictive value of CSF pleocytosis in relation to the EV
RT-PCR result were 89, 60, 53, and 91%, respectively.
Interestingly, of the 28 patients who tested EV RT-PCR
positive without CSF pleocytosis, 25 (89%) were in the ⱕ2
months age group (Table 2). These patients accounted for 30%
of the 83 patients in this age group who were EV RT-PCR
positive. In comparison, pleocytosis was absent in only 3 of 160
patients (1.9%) aged ⬎2 months who were EV RT-PCR positive (P ⬍ 0.001). This difference translates into large agerelated differences in the sensitivities and negative predictive
values for CSF pleocytosis in relation to EV RT-PCR (70%
sensitivity and 74% negative predictive value for samples from
patients ⱕ2 months of age, 98% sensitivity and 98% negative
predictive value for samples from patients aged 2 months to 18
years, and 100% sensitivity and 100% negative predictive value
for patients aged ⬎18 years) (Table 2).
In contrast to the finding that lack of pleocytosis in CSF
specimens that were EV RT-PCR positive was most common
in samples from patients in the ⱕ2 months age group, the
presence of pleocytosis in specimens that were EV RT-PCR
negative was more common for older patients. Overall, pleo-

2001
All ages
ⱕ2 mo
⬎2 mo and
ⱕ18 yr
⬎18 yr
2002
All ages
ⱕ2 mo
⬎2 mo and
ⱕ18 yr
⬎18 yr
2003
All ages
ⱕ2 mo
⬎2 mo and
ⱕ18 yr
⬎18 yr
All years
All ages
ⱕ2 mo
⬎2 mo and
ⱕ18 yr
⬎18 yr

Present

Absent

Sensitivity
(%)

Specificity
(%)

PPV
(%)

NPV
(%)

PCR⫹

PCR⫺

PCR⫹

PCR⫺

100
28
59

43
5
19

17
18
2

83
20
47

85
65
97

66
80
71

70
85
76

83
57
96

13

19

0

16

100

46

41

100

39
19
18

77
10
32

5
5
0

98
13
50

89
79
100

56
57
61

34
66
36

95
72
100

2

35

0

35

100

50

5

100

77
11
60

74
11
38

6
5
1

109
37
44

93
69
98

60
77
54

51
50
61

95
88
98

5

26

0

28

100

52

16

100

216
58
137

194
26
89

28
25
3

290
70
141

89
70
98

60
73
61

53
69
61

91
74
98

20

80

0

79

100

50

20

100

a
PCR⫹, positive EV RT-PCR results; PCR⫺, negative EV RT-PCR results;
NPV, negative predictive value.

cytosis was present in 194 (40.1%) of the 484 specimens that
were EV RT-PCR negative, and it was present in 27% of
specimens from patients in the ⱕ2 months age group, in 39%
of specimens from patients in aged 2 months to 18 years, and
in 50% of specimens from the ⬎18 years age group. These
findings correspond to lower specificities and PPVs for pleocytosis with increasing age (73% specificity and 69% PPV for
those patients ⱕ2 months of age, 61% specificity and 61% PPV
for those patients aged 2 months to 18 years, and 50% specificity and 20% PPV for those patients aged ⬎18 years). The
PPVs for patients ⬎2 months of age were lowest in 2002, the
year that the St. Louis area experienced a large outbreak of
West Nile virus (WNV) disease. During this year, the PPV of
pleocytosis for a positive RT-PCR was only 36% in the 2
months to 18 years age group and 5% in those over 18 years of
age.
We next investigated the possibility that elevated CSF protein level could be used as a marker for EV infection. This
analysis was restricted to specimens obtained during the 2001
and 2002 seasons. Of the 465 patients for whom CSF protein
values were available, 161 were RT-PCR positive, and 192 had
elevated levels of CSF protein. For all ages, the sensitivity,
specificity, PPV, and negative predictive value of elevated protein levels in relation to the results of RT-PCR were 38.5%,
61.1%, 47.8%, and 51.7%, respectively, in 2001 and 43.2%,
54.9%, 19.4% and 79.3%, respectively, in 2002. Sensitivities
and specificities were low in all age groups and in all years
(data not shown). We also examined two other combinations
of parameters in relation to the RT-PCR result: the presence
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infect humans (13). The six EVs that were not detected are epidemiologically
rare.
A z-test was used to test the hypothesis that there were no differences in
sensitivities and specificities between the data from 2001 and 2002, the first two
years of the study.

Year and age
group

No. of samples with indicated
EV RT-PCR result when
pleocytosis is:
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TABLE 3. Z-tests for comparison of two sets of statistical data
Age group and marker

Sensitivity
2001 2002

P

⫺0.669
⫺1.024
⫺1.703
⫺0.13

0.5031
0.3058
0.0886
0.8966

0.66
0.61
0.79
0.48

0.137

0.80 0.57

2.443 0.0145 0.85 0.66 2.01

⫺0.452 0.651

0.71 0.61

1.506 0.131

0 to ⱕ2 mo

0.65 0.79 ⫺1.49

⬎2 mo to ⱕ18 yr

0.97 1.0

⬎18 yr

1.0

a

1.0

0.56
0.55
0.70
0.41

z-test

2.138
1.351
1.516
2.209

0.46 0.50 ⫺0.44

P

2001 2002 z-test

P

2001 2002

z-test

P

0.0325
0.1767
0.129
0.027

0.66

0.044 0.57 0.72 ⫺1.593 0.111

0.76 0.36 6.026 ⬍0.001 0.96 1.0
0.41 0.05 3.96

⬍0.001 1.0

1.0

⫺0.602 0.547
0

NPV, negative predictive value.

of both pleocytosis and elevated protein levels, and the presence of either pleocytosis or elevated protein levels. Neither of
these combinations appeared useful: using pleocytosis plus elevated protein levels resulted in decreased sensitivity in relation to RT-PCR, whereas results with either pleocytosis or
elevated protein level were very similar to those with pleocytosis alone (data not shown).
In an effort to improve the sensitivity of elevated protein
levels for the prediction of EV RT-PCR positive specimens, we
evaluated the effect of lower protein cutoff levels on the correlation. The receiver operating characteristic curves for the
three different protein cutoff levels (i.e., the normal levels as
given in Materials and Methods, 80% of the normal levels, and
60% of the normal levels) and for the three age groups of
patients showed that there was not a particularly good CSF
protein cutoff level for use as an indicator of EV RT-PCR
positivity, since none of the points on any of the curves indicated greater than 80% sensitivity and also greater than 80%
specificity (i.e., less than 0.2 on the [1-specificity] axis) (data
not shown).
Since WNV was first present in our area during the 2002 EV
season but had not been present during the 2001 season, we
sought to determine whether the presence of WNV made a
noticeable difference in the relationship between the CSF profile and the results of EV RT-PCR. We used the z-test to
compare the sensitivities and specificities of CSF pleocytosis
and elevated CSF protein levels in relation to the EV RT-PCR
results for the two years for all age groups. The results are
shown in Table 3. Of note was the fact that the specificity of
pleocytosis as a predictor of the EV RT-PCR result in patients
of all ages decreased from 66% in 2001 to 56% in 2002 (P ⫽
0.03), suggesting the possibility of the presence of a group of
patients with pleocytosis resulting from WNV infection (Table
3). Curiously, the difference in specificities between the two
years was only significant for the ⱕ2 months age group (80% in
2001 versus 57% in 2002) (Table 3). Of particular note was the
eightfold decrease in PPV in the ⬎18 years cohort, where the
PPV was 41% in 2001 and only 5% in 2002 (P ⬍ 0.0001) (Table
3); this is not surprising and probably reflects the fact that
WNV meningitis and encephalitis are more common in adults
than in children.
During 2002, a total of 77 patients for whom CSF parameters were available had pleocytosis and a negative EV RT-

PCR. Alternative diagnoses were established virologically
(based on positive PCR assays or serology) for 18 patients
(15%), including 10 with WNV infection, 4 with herpes simplex
virus (HSV), 3 with Epstein-Barr virus (EBV), and 1 with both
HSV and EBV. None of the 77 patients had a positive culture
for a bacterial pathogen associated with meningitis.
DISCUSSION
Nucleic acid amplification using RT-PCR or other techniques provides a more accurate diagnosis of EV meningitis
than previously available techniques such as viral culture. With
the availability of these sensitive diagnostic techniques, many
CSF specimens are now submitted for EV nucleic acid testing.
We have monitored the CSF profile, including leukocyte count
and protein level, to help assess the performance of the EV
RT-PCR used in our laboratory. We have now analyzed the
data based on specimens submitted for EV RT-PCR during
the 3-year period of 2001 to 2003 to reassess the relationship
between CSF parameters and the presence of EV infection of
the central nervous system (CNS). During one of those years,
a large outbreak of WNV occurred in our area, allowing us to
evaluate the impact of the presence of another neurotropic
pathogen on the relationship between abnormalities in the
CSF profile and the possible presence of EV RT-PCR. Our
findings may be useful for clinicians and laboratory workers
seeking to optimize their use of EV nucleic acid testing.
The main focus of our study was the relationship between
CSF leukocyte counts and the results of EV RT-PCR. We were
interested in determining the proportion of patients with both
EV CNS infection and an elevated CSF leukocyte count. We
were also interested in determining the proportion of patients
with elevated CSF leukocyte counts that were accounted for by
EV infection. Our data show that both of these proportions are
strongly influenced by age. The finding of a lack of CSF pleocytosis in CSF samples that were positive for EV RNA was
largely limited to infants under 2 months of age and was quite
common (28%) in this age group, probably reflecting the immunologic immaturity of these patients. It is tempting to speculate that a chemokine response required for the recruitment
of leukocytes to the site of infection had not yet developed in
these patients. Among older patients, fewer than 2% of those
with EV infection of the CNS lacked pleocytosis. Conversely,
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0.86
0.39
0.36
0.88

2001 2002

NPVa

PPV

z-test

All ages
Pleocytosis
Protein elevated
Pleocytosis and protein
Pleocytosis and/or protein

0.89
0.43
0.43
0.89

Specificity
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PCR positivity was considered. However, the data showed that
the CSF protein level was neither sensitive nor specific when
used by itself, nor did it increase the sensitivity or specificity
when used in conjunction with pleocytosis. The receiver operating characteristic curves showed that the CSF protein level
alone never had greater than 80% specificity at any of the
cutoff levels investigated, and in no age group nor at any of the
three levels we investigated were both the sensitivity and specificity greater than 80%. The best correlation between CSF
protein levels and EV RT-PCR positivity occurred in patients
who were ⬎2 months old at 80% of the normal cutoff, where
the sensitivity was 68% and the specificity was 78%.
The circulation of WNV in the community during the 2002
EV season was potentially a confounding factor in using CSF
markers as correlates of EV RT-PCR positivity. Indeed, the
z-test data of Table 3 confirm that there were significant differences between data from the 2001 and 2002 seasons on the
specificities of pleocytosis alone or pleocytosis and/or elevated
protein level as correlates of EV RT-PCR positivity, perhaps
due to the presence of WNV in St. Louis during the 2002
season. In 2002, there were 67 CSF specimens from patients
who were ⬎2 months old who had pleocytosis that were negative by EV PCR. Of these, 10 (15%) were positive for WNV
and 18 (27%) were positive for either WNV or another virus.
If all 18 of these false positives were removed from the 2002
calculations, specificity and PPV increased from 56% and 23%,
respectively, to 63% and 29%. The specificity and PPV for all
specimens from patients who were ⬎2 months old in 2001 were
62% and 66%, respectively. Removing the false positives that
were attributable to the presence of other viruses still does not
account for the drop in PPV from 2001 to 2002. Other unknown factors must be at work. Thus, the presence of another
cause (infectious or otherwise) of CSF pleocytosis in the community decreases the ability of the laboratory to predict EV
positivity based on CSF findings.
In addition to focusing attention on the CSF pleocytosis
causes other than EV infection, the results of this study have
two practical applications. The first is that laboratories performing EV RT-PCR can use the comparison of the RT-PCR
results to CSF cell counts to develop metrics that can be used
as part of a quality assurance program for that assay. Based on
our experience, one metric is that the EV RT-PCR should be
positive in approximately 75% of infants less than 2 months of
age with CSF pleocytosis, in approximately 65% of infants and
children aged 2 months to 18 years with CSF pleocytosis, and
in approximately 25% of patients over 18 years of age with CSF
pleocytosis. These figures are derived by using data from the
two seasons when WNV was either absent or not very common. The circulation of known or new arboviruses or other
viruses that may cause meningitis should be considered for the
analysis of data related to this metric, because it will cause a
decrease in the proportion of patients with pleocytosis who
have a positive EV RT-PCR result. Laboratories that do not
meet this standard may benefit from investigating the analytic
sensitivity of their assay but should also be alert to the possible
presence of other agents that might cause CSF pleocytosis.
A second metric that can be used for quality control is that
the EV RT-PCR assay should be negative in approximately
98% of patients over 2 months of age who lack CSF pleocytosis, and in approximately 70% of patients under 2 months of
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the finding of CSF pleocytosis with a negative EV RT-PCR was
more common among samples from older patients. Not surprisingly, this finding was also more common during the season
when a sizable outbreak of WNV disease occurred in the area
served by our laboratory.
Previous smaller studies have also focused on a comparison
of EV RT-PCR results and CSF parameters. Henquell et al.
(5) reported on 61 patients with symptoms of meningitis and
compared EV culture and PCR results with CSF findings.
Fifty-six of the 61 patients (92%) were PCR positive, but 9
patients who were ⬎1.5 years of age had CSF cell counts of
⬍10 cells/mm3 and were PCR or culture positive. Thus, in their
study, the correlation between pleocytosis and EV RT-PCR
positivity was not good. Böttner et al. (2) reported on a cohort
of 70 patients with symptoms of meningitis during the summer
of 2000. In that study, 29 (46%) of 61 EV RT-PCR assays on
CSF were positive. CSF cell counts ranged from 2 to 1,820
cells/mm3, with a mean of 151. The authors reported that there
were no differences in laboratory findings between the patients
in their study who were EV RT-PCR positive and those who
were negative, but they did not provide detailed CSF cell
counts. The explanation for the differences between results of
those studies and the present study is not clear, but it could
reflect biological differences in the EVs being detected or
different performance characteristics of the EV RT-PCR assays.
One of the interesting aspects of the present study is to focus
attention on the causes of CSF pleocytosis in patients whose
EV RT-PCR assay is negative. One possible explanation is that
the assay may not detect all EV infections. We do not know the
actual analytic (molecular) sensitivity of the Chemicon assay in
terms of its ability to detect low levels of viral RNA. We have
investigated the sensitivity and found it to be on the order of
2.0 times the 50% tissue culture infectious dose, but we do not
know how many EV genomes this represents, nor is it known
how many noninfectious particles are produced in an acute
infection in human CSF. However, this is unlikely to be the
only explanation since, in our study, 21 of 148 patients (14%)
who were ⱕ2 months old and 169 of 549 patients (31%) who
were ⬎2 months old had pleocytosis and were EV RT-PCR
negative. The primers and probe used in our study have been
shown to detect all but 6 of the 64 known EVs that infect
humans (13). One EV, coxsackievirus A15, was not available
for testing, and two others that were not detected with this
primer and probe combination, echoviruses 22 and 23, have
since been reclassified as parechoviruses (16). The six EVs that
were not detected are epidemiologically rare. Other infections,
such as HSV, EBV, and WNV, were diagnosed in some of the
patients with pleocytosis but accounted for only 18 infections
or 23% of all patients in this study with pleocytosis and a
negative EV RT-PCR in the year 2002 (n ⫽ 77). It is possible
that some of the remaining patients had infections with other
infectious agents, such as parechoviruses (16). Additionally,
some of the observed cases of pleocytosis in this study may
have been due to noninfectious causes of pleocytosis, including
reactions to medications such as cotrimoxazole, nonsteroidal
anti-inflammatory agents, and intravenous immunoglobulin.
Bacterial urinary tract infection has also been implicated as a
cause of CSF pleocytosis in children (18).
The use of CSF protein levels as an indicator of EV RT-
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age without pleocytosis. The detection of EV RNA in a larger
percentage of patients who lack pleocytosis should cause laboratories to consider whether PCR contamination may be
present. It should be noted, however, that these percentages
will likely vary from one region to another, from one patient
population to another, from one diagnostic assay to another,
and from one season to another, possibly depending on the EV
that is circulating.
The second practical application of the findings from the
present study is that laboratories may use this data to establish
criteria to maximize the efficiency of EV RT-PCR testing. For
example, because the absence of pleocytosis has a predictive
value of greater than 98% for a negative RT-PCR result in
patients over 2 months of age, laboratories may choose to
establish a cutoff for EV RT-PCR testing based on the presence or absence of pleocytosis. Using the data from the present
study, the application of this cutoff would have resulted in
excluding 223 of 549 specimens (based on the 549 specimens
from patients who were ⬎2 months of age for which CSF cell
counts were available), with a failure to detect only 3 positive
specimens (1.3%) which would have been in the excluded
group of 223 samples. The three patients with EV infection but
no pleocytosis were 5 months, 10 years, and 15 years old. One
of these patients (the 10 year old) was suspected of having EV
meningitis by virtue of a stiff neck, but the other two had
symptoms that were less clearly associated with meningitis. The
10-year-old patient would likely have been tested for EV based
on clinical suspicion rather than CSF pleocytosis, but the other
two might not have been tested. For all three cases, the positive
EV PCR result did not significantly impact the case management. If a measure such as we have suggested is adopted, we
recommend applying it to patients over 2 months of age and
ensuring that a mechanism exists that would allow testing in
individual cases with a strong clinical suspicion of EV infection, regardless of the patient age or presence of CSF pleocytosis. Obviously, a screening program based on CSF pleocytosis is practical only for laboratories whose access to CSF cell
count data is sufficiently rapid that the application of the
screening criterion would not delay the performance of the
assay. Previous studies have clearly demonstrated that EV assays must be performed in a very timely fashion in order to
have an impact on clinical decision making (14).
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